Amr El-Refaey, Medical Affairs and New Therapy Areas Lead at the Globalpharma LLC, shared a post on LinkedIn:
“IQVIA Report, August 2025!
Oncology Therapy Access in the Era of Personalized Medicine!
Trends in Regulatory Approval and Reimbursement for Select Countries in the Middle East and Africa!”
Read the full report.
More posts about IQVA on OncoDaily.